Literature DB >> 2217153

Neural patterns in inflammatory bowel disease: an immunohistochemical survey.

R S Strobach1, A H Ross, R S Markin, R K Zetterman, J Linder.   

Abstract

The differential diagnosis of inflammatory bowel disease remains a significant diagnostic problem for surgical pathologists. Neural abnormalities, such as hypertrophy of nerve plexi, hyperplasia of ganglion cells, and ultrastructural axonal degeneration have been described in patients with regional enteritis. We performed an immunohistochemical survey of forty cases of regional enteritis, ulcerative colitis, nonspecific colitis, and normal colon. A panel of antibodies, directed against neuron-specific enolase, S-100 protein, synaptophysin, neurofilament protein, and nerve growth factor receptor, was utilized to evaluate the distribution of nerve fibers in paraffin-embedded tissue. Anti-synaptophysin and anti-nerve growth factor receptor highlighted small, arborizing nerve fibers in the mucosa, not apparent in the routinely stained sections. Intense staining of these fibers was observed in regional enteritis with antinerve growth factor receptor. This antibody may aid the discrimination of inflammatory bowel disease from other causes of colonic inflammation and facilitate the identification of regional enteritis in endoscopic biopsies.

Entities:  

Mesh:

Year:  1990        PMID: 2217153

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  8 in total

1.  Damage to the enteric nervous system in experimental colitis.

Authors:  S Sanovic; D P Lamb; M G Blennerhassett
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

2.  Homeostatic and therapeutic roles of VIP in smooth muscle function: myo-neuroimmune interactions.

Authors:  Xuan-Zheng Shi; Sushil K Sarna
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-08-06       Impact factor: 4.052

3.  Nerve growth factor and Trk high affinity receptor (TrkA) gene expression in inflammatory bowel disease.

Authors:  F F di Mola; H Friess; Z W Zhu; A Koliopanos; T Bley; P Di Sebastiano; P Innocenti; A Zimmermann; M W Büchler
Journal:  Gut       Date:  2000-05       Impact factor: 23.059

4.  Impaired synthesis or cellular storage of norepinephrine, dopamine, and 5-hydroxytryptamine in human inflammatory bowel disease.

Authors:  F Magro; M A Vieira-Coelho; S Fraga; M P Serrão; F Tavarela Veloso; Tomé Ribeiro; P Soares-da-Silva
Journal:  Dig Dis Sci       Date:  2002-01       Impact factor: 3.199

5.  Experimental colitis in mice is attenuated by changes in the levels of endocannabinoid metabolites induced by selective inhibition of fatty acid amide hydrolase (FAAH).

Authors:  M Sałaga; A Mokrowiecka; P K Zakrzewski; A Cygankiewicz; E Leishman; M Sobczak; H Zatorski; E Małecka-Panas; R Kordek; M Storr; W M Krajewska; H B Bradshaw; J Fichna
Journal:  J Crohns Colitis       Date:  2014-02-14       Impact factor: 9.071

6.  Cannabinoids alleviate experimentally induced intestinal inflammation by acting at central and peripheral receptors.

Authors:  Jakub Fichna; Misha Bawa; Ganesh A Thakur; Ritesh Tichkule; Alexandros Makriyannis; Donna-Marie McCafferty; Keith A Sharkey; Martin Storr
Journal:  PLoS One       Date:  2014-10-02       Impact factor: 3.240

Review 7.  Neuroimmunomodulation in the Gut: Focus on Inflammatory Bowel Disease.

Authors:  Claudio Bernardazzi; Beatriz Pêgo; Heitor Siffert P de Souza
Journal:  Mediators Inflamm       Date:  2016-07-04       Impact factor: 4.711

8.  Inflammation and tissue remodeling contribute to fibrogenesis in stricturing Crohn's disease: image processing and analysis study.

Authors:  Mustafa Erdem Arslan; Rupinder Brar; Lianna Goetz; Dipti Karamchandani; Michael W Mikula; Kyle Hodge; Hua Li; Sangtae Ahn; Hwajeong Lee
Journal:  J Pathol Transl Med       Date:  2022-07-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.